| | What you need to know about the coronavirus today |
The ozone effect Japanese researchers said low concentrations of ozone can neutralize coronavirus particles, potentially providing a way for hospitals to disinfect examination rooms and waiting areas. Scientists at Fujita Health University told a news conference they had proven that ozone gas in concentrations of 0.05 to 0.1 parts per million, levels considered harmless to humans, could kill the virus. The experiment used an ozone generator in a sealed chamber with a sample of coronavirus. The potency of the virus declined by more than 90% when subjected to low level ozone for 10 hours. | | | |
Fears of second wave in France A second wave of the coronavirus pandemic could hit France in November, a government advisor told local media, as the city of Marseille tightened restrictions to fight the outbreak. Authorities in Marseille said that bars and restaurants would have shorter opening times, and they also broadened mandatory mask-wearing in the southern port city between Aug. 26 and Sept. 30. Seoul doctors ordered back to work South Korea ordered doctors in the Seoul area to return to work on Wednesday as they began a three-day strike in protest against several government proposals, including one to boost the number of doctors to deal with crises like the coronavirus. Trainee doctors have been staging ongoing walkouts, and thousands of additional doctors were due to stage a three-day strike. Lessons from India’s Silicon Valley The early COVID-19 response in Bengaluru, dubbed India’s Silicon Valley for its tech firms and startups, was lauded by India’s government as a model, for its use of health surveys combined with efforts to tap tech expertise and cutting-edge software to analyse the spread of the disease. But after India eased a nationwide lockdown in early June, officials say tens of thousands of travelers streamed in from Maharashtra and Tamil Nadu, many unwittingly bringing the virus. The neighbouring states have been the two worst hit by COVID-19 in India. “We didn’t look at the inbound travellers as a major source of infections,” said one official involved in Bengaluru’s response. “We never anticipated that many people would come.” | |
From Breakingviews - Corona Capital: Drugs, Gold miner, Japan food M&A. COVID-19 vaccine makers may provoke unfortunate consequences by seeking protection from lawsuits, and the pandemic burnishes UK-listed gold miner Polymetal’s allure. Catch up with the latest financial insights here. | |
Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic. We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources. Here’s a look at our coverage. Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages? We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com. We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | |
|
| |